of life-sustaining therapies for neurocritically ill patients. Based on review of these articles and the experiences of our interdisciplinary/interprofessional expert advisory board, this report was prepared to guide critical care staff, palliative care specialists, and others who practice in this setting. Conclusions: Most neurocritically ill patients and their families face the sudden onset of devastating cognitive and functional changes that challenge clinicians to provide patient-centered palliative care within a complex and often uncertain prognostic environment. Application of palliative care principles concerning symptom relief, goal setting, and family emotional support will provide clinicians a framework to address decision making at a time of crisis that enhances patient/family autonomy and clinician professionalism. (Crit Care Med 2015; 43:1964-1977 Key Words: end-of-life care; intensive care unit; neurocritical care; neurointensive care unit; palliative care a Among patients with severe traumatic brain injury. b Overall 90% mortality including those who do not survive to hospital admission (109). c Among patients who underwent targeted temperature management. Mortality rates are higher and functional outcome worse in patients with pulseless electrical activity/asystole arrest compared with ventricular fibrillation/ventricular tachycardia arrest. d Patients with refractory status epilepticus (continued seizures after two antiepileptic drugs have been administered) have higher mortality rates and worse functional outcomes.
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For information regarding this article, E-mail: frontej@ccf.org Objectives: To describe unique features of neurocritical illness that are relevant to provision of high-quality palliative care; to discuss key prognostic aids and their limitations for neurocritical illnesses; to review challenges and strategies for establishing realistic goals of care for patients in the neuro-ICU; and to describe elements of best practice concerning symptom management, limitation of life support, and organ donation for the neurocritically ill. Data Sources: A search of PubMed and MEDLINE was conducted from inception through January 2015 for all English-language articles using the term "palliative care, " "supportive care, " "end-of-life care, " "withdrawal of life-sustaining therapy, " "limitation of life support, " "prognosis, " or "goals of care" together with "neurocritical care, " "neurointensive care, " "neurological, " "stroke, " "subarachnoid hemorrhage, " "intracerebral hemorrhage, " or "brain injury. " Data Extraction and Synthesis: We reviewed the existing literature on delivery of palliative care in the neurointensive care unit setting, focusing on challenges and strategies for establishing realistic and appropriate goals of care, symptom management, organ donation, and other considerations related to use and limitation N eurocritical illness, defined as critical illness primarily involving the brain, spinal cord, or neuromuscular system (1) , is often a sudden, catastrophic event for patients and their families. Although advances in neurocritical care continue to improve outcomes, mortality rates for common conditions including intracerebral hemorrhage (ICH) and anoxic brain injury range above 50%, and many patients never regain functional independence ( Table 1) . Patients often experience significant cognitive loss along with deterioration in quality of life (2, 3) . Even for those who survive without permanent disabilities, recovery from neurologic injury can be prolonged and accompanied by physical and psychological distress for patients, as well as practical and emotional burdens for families. For these reasons, palliative care, including communication about goals of care in relation to the patient's condition, prognosis, and preferences, is an important component of high-quality care in the neurocritical care environment.
Palliative care focuses on relief of symptoms, effective communication about goals of care, alignment of treatment with patient preferences, family support, and planning for transitions (4, 5) . Whereas hospice or end-of-life care is for patients approaching death, palliative care is appropriate in the context of any serious illness, regardless of stage or prognosis, and is optimally provided together with, not in lieu of, disease-directed or life-prolonging treatment. Palliative care is an interprofessional specialty, but also an approach for all clinicians caring for seriously ill patients who are expected to provide excellent "generalist"-level palliative care (6) .
In this article, Improving Palliative Care in The ICU Project Advisory Board brings interdisciplinary and interprofessional expertise together to address challenges and strategies regarding prognostication, communication, and decision making for the neurocritical care patient and family.
ONSET AND TRAJECTORY OF NEUROCRITICAL ILLNESS
The onset of neurocritical illness is usually abrupt and follows a trajectory that is distinct from that of other patients with lifethreatening illness ( Fig. 1) (7, 8) . Neurocritically ill patients often face a sudden and total transformation from good health and independence to the prospect of death or serious and permanent disability. Over 70% of patients in the neuro-ICU have no premorbid symptoms and present with a precipitous loss of physical and cognitive function (9, 10) . Therefore, from the onset, clinicians face the challenge of helping families cope with the impact of an unexpected and devastating illness, making it more difficult to focus on the decision-making process.
Decision making is further complicated by the unpredictable and extended course of many forms of neurocritical illness. Often, (128, 129) patients do not progress to death (by cardiovascular or brainbased criteria) after neurologic injury, but instead either improve slowly over several months or stagnate in a severely disabled state. Most deaths among the neurocritically ill patients occur after limitation of life-sustaining therapies. Nationally, 13.5-15% of patients in neuro-ICUs have life-sustaining therapies withheld or withdrawn, and limitation of such therapies precedes up to 61% of all deaths in the neuro-ICU (9) (10) (11) . In those who do not die, recovery is prolonged. Brain-injured patients make their maximal spontaneous recovery over 3-6 months, though improvement can continue over the ensuing months with aggressive rehabilitation (12) (13) (14) (15) . Therefore, neurologic changes that would affect decision making often occur well after the ICU and hospital stay, necessitating the use of prognostic scales that can assist in early discussions about goals of care.
PROGNOSIS: TOOLS AND LIMITATIONS
For some forms of neurocritical illness, specific clinical and radiographic features are predictive of poor neurologic outcome across a number of studies ( Table 2 ) (16) . However, these predictors were derived primarily from observational studies, refer to a variety of time frames as outcomes, and have other limitations as outlined below. In general, the loss of brainstem reflexes, with radiographic confirmation of destruction of the brainstem or diffuse cortical infarction, is incompatible with meaningful functional recovery. Though survival is possible, the anticipated quality of life is often deemed unacceptable. In circumstances where the prognosis is less certain, it is important for clinicians to know the strengths and weaknesses of existing outcome data and prognostic models. Addressing uncertainty is an important part of communicating with patients and families to establish realistic goals of care. A variety of prognostic scales offer useful outcome estimates for common neuro-ICU conditions ( Table 3 ). The Glasgow Coma Scale (17) was developed for patients with traumatic brain injury (TBI). This scale (assessing eye opening, motor response, and verbal response, with lower scores reflecting more severe injury) is often used for serial abbreviated neurologic examinations and provides a globally recognized standard in neurologic assessment. The Glasgow Coma Score is a highly reliable predictor of in-hospital mortality, but it has limited use for predicting long-term functional outcome of survivors. This scale has been applied across a wider spectrum of neurologic diagnoses, including intracranial hemorrhage (18) . The National Institutes of Health Stroke Scale is one of the most reliable instruments to predict outcome after ischemic stroke (19) . In North America, the Hunt-Hess Grade (20) for subarachnoid hemorrhage (SAH) is highly correlated with mortality and functional outcome. The ICH (18) and FUNC (21) scores are used to predict mortality and functional outcomes, respectively, after ICH. These scales were developed to estimate the most likely outcome, though application on an individual level is more complex.
Impact of Withdrawing Life-Sustaining Treatment
Most studies describing the outcome of patients with severe brain injury have included patients from whom life-sustaining therapy was withheld or withdrawn. Yet, studies of ICH, SAH, and TBI patients have found that an early "do not attempt resuscitation" (or do not resuscitate [DNR]) directive and/or withdrawal of life-sustaining treatment as much as doubled the short-and long-term mortality, even after adjusting for known predictors of mortality (age, gender, ethnicity, Glasgow Coma Scale, ICH volume, intraventricular hemorrhage, and infratentorial hemorrhage) (22) (23) (24) (25) (26) . Thus, reliance on existing mortality data for prognostication can give rise to a "self-fulfilling prophecy" and perpetuate high mortality rates. Inclusion of patients undergoing early limitation of life support can confound the development of new prognostic models and hamper clinical trials to develop life-saving interventions for neurocritically ill patients. However, it is ethically important to offer families the option of withdrawal of life support in keeping with the patient's right to autonomy and right to make an informed decision. A possible approach to this conundrum would be to use functional outcomes rather than mortality as primary endpoints. The development of new technologies and methodologies to predict outcome (27) after neurologic injury is essential to improving the design of clinical trials and strengthening the ability of clinicians and families to make informed decisions about appropriate goals of care.
Model Characteristics
Models that predict functional outcome and quality of life, rather than mortality alone, would be more valuable for both clinicians and families. However, existing functional outcome scores (such as the Glasgow Outcome Score [28] or the modified Rankin Score [29, 30] ) are heavily weighted toward motor ability and do not take into account other important outcomes, such as cognitive and emotional function and quality of life, which are of utmost importance to patients and families (31, 32) . Prediction models for quality of life after neurocritical care have not been robustly developed, and proxy assessment tools to measure quality of life are scant and not well validated. Many studies use dichotomized outcomes, with arbitrary and varying cutpoints that may not be meaningful for patients and their families. For example, the modified Rankin Scale (29, 30) , which ranges from 0 (no symptoms) to 6 (death), is variably dichotomized as 0-3 (0 = no symptoms, 3 = moderate disability requiring some help but able to walk without assistance) versus 4-6 (4 = moderately severe disability; unable to walk without assistance or attend to bodily needs, 6 = death), or as 0-1 (0 = no symptoms, 1 = no significant disability despite symptoms) versus 2-6 (2 = slight disability but able to carry out own affairs, 6 = death). Depending on the cutpoint used, study results may significantly differ. In addition, trials yielding data used to generate prognostic scales often exclude the most severely affected patients, for whom little data are then available regarding the impact of treatments. Finally, models used for prognostication project what happens to a population on average; they cannot predict the outcome of any given individual. Adjustment for case-mix and the use of patient-or family-reported outcomes in future studies may help improve prognostication, but, importantly, such models will always suffer from this inherent limitation (33, 34) . Models that predict functional recovery are also limited by the challenges in predicting an individual patient's ability to adapt (response shift) to a neurologic deficit that the patient has not yet experienced, as well as reframing or changing perceptions of quality of life that can occur over time (35, 36) .
Models based on Outdated Practice or Lacking Adequate Validation
Older prognostication tools may reflect outdated medical and surgical practices that have evolved to offer patients a chance of The risk of poor outcome in patients who are 60 yr old or younger with large hemispheric stroke is attenuated by decompressive hemicraniectomy. Mortality is reduced from 71% to 22% with hemicraniectomy versus medical management (p < 0.0001) and the chance of moderate disability (able to walk without assistance or better) at 12 mo was 43% with hemicraniectomy versus 21% without (p = 0.014) (103 better neurologic recovery (37) . In addition, certain commonly used scales have not been validated or rigorously tested in different cohorts (38) .
Practitioner Variability
Survey results suggest that many physicians are both overly pessimistic and inaccurate in predicting outcome, particularly within the first 72 hours of neurocritical illness (22, 39) . There is also significant variation in physician perception of prognosis in case-based scenarios (40) . In addition, early medical and surgical interventions in many neurocritical illnesses can substantially alter a patient's clinical course. In recognition of these and other factors, the American Heart Association together with the American Stroke Association recommends that new DNR orders be deferred and full intensive care therapy be administered after ICH at least until the second day of hospitalization (41) . An initial trial of full intensive care therapy is also generally appropriate for the first 24-72 hours in other types of neurocritical illness, unless the patient has a condition outlined in Table 2 or clearly expressed a different preference through advance care planning. A longer period of observation would be appropriate when functional recovery is particularly difficult to predict and may continue over weeks to months, as for a young patient with TBI.
Conversely, some physicians are overly optimistic when discussing prognosis with patients and families (42) . The motivation for this optimism may be to maintain hope for recovery, and/or avoid emotionally laden encounters with patients or surrogates. Physicians also experience feelings of professional failure that make it difficult to acknowledge that the patient faces almost certain death or devastating neurologic impairment (43) . Although hope may help patients and surrogates cope with a serious illness, false hope tends to undermine the clinician-patient relationship, as well as delay appropriate decision making (44) .
PUbLIC PERCEPTIONS OF RECOVERY
Patients' and families' perceptions of neurocritical illness may be influenced by portrayals in film and other media that distort the reality of coma, persistent vegetative state, or minimally conscious state and tend to exaggerate the recovery prospects. In a review of 30 movies between 1970 and 2004, only two were found to represent coma realistically and 60% of coma patients portrayed in films awoke suddenly, even after a prolonged period of time, with intact cognition and physical function (45) . Although 15-50% of patients with persistent vegetative state regain consciousness over 1 year, depending on the mechanism of injury, the majority of these patients remain moderately-severely disabled and only 7% make a functional recovery, defined as mobile, able to communicate, and perform activities of daily living (46, 47) . Overall, the life expectancy for patients in persistent vegetative state is 2-5 years (48) . Patients with minimally conscious state (defined by intermittent command following and/or some ability to interact with their environment) have better long-term outcomes than those with persistent vegetative state, but still, most remain disabled and dependent (49) . "Medically induced coma" has a very different prognosis for recovery than coma resulting from illness or injury, but this distinction is frequently blurred in the media and poorly understood by the public (50) . To address potential misperceptions, clinicians need to explore the family's understanding of the nature and likely outcomes of the patient's condition, focus on the unique clinical circumstances, and endeavor to bring the family's perceptions and expectations into closer alignment with medical realities. A public education effort addressing the realities of brain injury is needed.
STRATEGIES FOR ESTAbLISHING GOALS OF CARE

Integrating the Interdisciplinary, Interprofessional Team
The expertise of a variety of clinicians can contribute to optimal care. We recommend that the clinical team (including intensivists, neurologists, and neurosurgeons) huddle at each critical discussion juncture to present a common message to the family, particularly when presenting prognosis and the uncertainty surrounding it. Physical therapists and neurorehabilitation specialists may be able to provide specific insight into expected longterm disabilities and the recovery process. Specialists in palliative care can support both the primary team and the family to address difficult decisions and complex symptoms. Ideally, involvement of such specialists is not deferred until the patient is imminently dying, since they are most effective when engaged early enough to build a trusting relationship with the family. At the same time, basic, generalist-level palliative care remains the responsibility of the primary team and should be part of daily practice. Both "specialist" and "generalist" models of palliative care are effective and a combined approach may represent the optimal model (51, 52) . Strategies for developing such models have been reviewed (52) . ICU staff can be trained to manage distressing symptoms and conduct interprofessional/interdisciplinary family meetings, while involvement of palliative care specialists can support the primary team, particularly in the most challenging situations, and provide continuity of care to the patient and family (52) . Bedside ICU nurses can offer significant contributions to communication about appropriate and realistic goals of care, especially when physician-nurse communication has been optimized (53) . Social work, psychology, ethics services, pastoral care, and case management services all have a role to play in helping families.
Timing of Goals of Care Discussions
Effective communication with patients and families balances honesty with empathy and hope (54) and proceeds in the context of the condition and prognosis as well as the values, goals, and preferences of the patient (55) . From the time of admission, available prognostic information, and all indicated treatment options should be openly discussed, along with a review of prior advance care planning so that the patient's wishes are respected. For patients without an advance directive, it is reasonable to initiate a time-limited trial of full intensive care therapy, except in extreme circumstances (e.g., brain death, poor premorbid function, low probability of successful intervention, and factors listed in Table 2 ). Early intervention may directly alter the patient's prognosis. 
Shared, Value-based, Decision Making
The patient's values, goals, and preferences provide the touchstone for communication and decision making. Whether or not the patient specifically articulated such wishes, shared decision making about appropriate goals of care entails discussion of the patient's values, including the quality of life that the patient would find acceptable. Especially in the context of neurocritical illness, in which patients may survive but with significant loss of function and cognition, the scope of discussion between clinicians and families must extend beyond a patient's chances for survival, to a fuller conversation about achievable goals in relation to the patient's condition, prognosis, and values. In these discussions, the focus must remain on the values of the patient, rather than concerns of the family, or views projected by the clinician. Table 4 outlines an approach that facilitates discussion of a patient's values as the basis for decision making (55) . Putting the physician's prognostic estimate of neurologic outcome together with the patient's goals and values allows for a process of shared decision making to develop a plan of care (Fig. 2) .
Communicating Prognosis
When offering an estimated prognosis for neurologic function, it can be helpful to communicate concrete skills, including activities of daily living, which the patient may or may not have a reasonable chance of achieving. For example, "the most likely outcome, should full, aggressive life support be applied, is that the patient will be completely dependent for all basic activities such as bathing, dressing, and toileting, and likely require a machine to breathe, a feeding tube, and placement in a nursing home." Or, "the patient will be weak on one side, and unable to walk, but still able to communicate and interact meaningfully with loved ones." It is important to describe not only potential deficits, but also skills that the patient is likely to retain, since certain deficits may be acceptable based on the patient's values or prior expressed wishes.
Families often inquire about signs of neurologic improvement that may alter prognosis. In general, for comatose patients, saccading (quick movements of both eyes in the same direction) to voice, tracking, and command-following are signs of improvement. One commonly misinterpreted interaction with the comatose patient is the grasp reflex. Since primitive reflexes can reemerge in the comatose state, families may believe that the patient is squeezing a loved one's hand purposefully. Careful explanation of reflexive movements is important for addressing family expectations, with recognition that the family may continue to interpret patients' movements differently (56) .
TAbLE 4. Steps in Discussing Goals of Care (54, 150)
Step 1
Introduce After ensuring a quiet setting where all participants can sit down, introduce the members of the clinical team and their roles. Ask family to introduce themselves and their relationship to the patient
Step 2 Empathize Express empathy and acknowledge that this is a difficult time and a challenging conversation. If the family is too emotionally overwhelmed to absorb and use information, continue responding empathically to the emotion before presenting information and decisions
Step 3 Inquire, inform, process emotional reactions
Inquire into the family's current understanding of the patient's condition. Clarify any gaps in understanding and update the family. Use of brain images may be useful for receptive families. Use of lay-person terminology is essential (e.g., bleeding in the brain, dead brain tissue). Allow families time to absorb information and ask questions
Step 4 Understand the patient's values Review advance care planning discussions and written advance directives, if available, with the family, and seek out information about patient and family values that can guide decision making
Step 5 Present prognosis Present the medical team's assessment of the patient's most likely prognosis in terms of future cognitive and functional outcome, acknowledging limitations and uncertainty in prognostication. Acknowledge the resulting emotional reactions to this information
Step 6 Present broad care options
Offer possible pathways of care that are clearly delineated. In the right context, care focused entirely on comfort should be presented as an alternative to continuation of intensive care therapies. This approach may become more acceptable over a series of iterative discussions
Step 7
Family decision making
Given the clinician's best estimate of the patient's long-term cognitive/functional outcome, and understanding the patient's values, ask the family to reflect on how the patient, if able, would decide in the present circumstances. If the family is receptive, the clinician can offer a professional recommendation based on best medical evidence and experience
Step 8 Match care goals to medical plan Adjust the care plan to match goals including review of current interventions, medications, and cardiopulmonary resuscitation/do-not-resuscitate status. Ask about specific goals of importance, such as living until an upcoming life event, or returning to home rather than a facility
Step 9
Reflection and questions
Ask the family to summarize their understanding of the conversation. Reflect back what you hear the family saying and summarize. Allow time for questions and offer the family time to discuss and consider the options
Step 10 Follow-up and document Make yourself available for follow-up conversations and questions. Document the results of the meeting in the medical record. Discuss plans with team members not present for the meeting
Addressing Prognostic Limitations
The limitations of current prognostic models should not preclude clinicians from sharing an opinion on the patient's potential outcome. Communication that acknowledges the uncertainty of outcome predictions can actually build trust and is consistent with a shared-decision model of patient-clinician communication and with empirical data about patients' and families' interest in prognostic information, even if there is uncertainty (57) . In addition, communication can acknowledge that prognosis is not based on the admission neurologic assessment alone, but may be altered by early treatment decisions, such as a decision to proceed with surgery. Besides consideration of disease-specific prognosis, clinicians should account for individual patient factors such as age, premorbid functional status, medical comorbidities, and admission neurologic and physiologic status that interact to affect prognosis (Fig. 2) (58) . Some studies suggest that the combination of model-based prediction with expert clinician outcome estimates may be superior to either approach alone (59) .
Addressing Family Guilt
Surrogates may feel guilt, doubt, and regret about their decisions, especially when the patient was healthy prior to a sudden neurologic catastrophe. Many surrogates carry these negative emotions for months to years (60) . To address and attempt to alleviate such distress, discussions may be framed in terms of the obligation to respect the patient's wishes, and the opportunity to help the patient preserve dignity when death is inevitable (61) . Intensive care support may only prolong the dying process, causing more suffering with the same eventual result.
Presenting Goals of Care Options
Communication about goals of care may be most effective when discussions are iterative, with continued discussion that takes account of the evolving clinical situation. Clear pathways of care, that is, full life support including tracheotomy and feeding tube placement versus care focused exclusively on comfort (often referred to as "comfort measures only"), are the two most typical treatment approaches for neurocritically ill patients. Although some physicians may offer partial treatment options rather than directly addressing realistic goals of care, this approach can confuse the family, and partial treatment plans can lead to the same outcome as a comfort measures only approach, but with prolongation of the dying process and preventable distress. A time-limited trial of full intensive care with observation for improvement may be helpful when the outcome is unclear (62) . The use of approaches such as "no escalation of treatment," which is another form of partial treatment, is more controversial (63, 64) . Families should be given adequate time to consider and modify goals of care and to place increasing emphasis on palliative care at any stage in the patient's course.
CONSIDERATIONS IN WITHDRAWAL OF LIFE-SUSTAINING THERAPIES Symptom Management During Withdrawal of Life Support
The withdrawal of life-sustaining therapies should follow a written protocol to ensure attention to all key elements, including documentation of the goals of care and the resuscitation status (65) . Consideration to family and visitor needs should be given when determining the timing of life support withdrawal. Although stroke and other neurocritically ill patients tend to have a lower symptom burden than otherseriously ill patients (66), pain, discomfort, and anxiety may cause distress even for a braininjured patient. Patients with spinal cord injury, terminal neuromuscular disease, stroke, brain tumor, and other conditions may also suffer from thirst, dyspnea, fatigue, sleep deprivation, incontinence, depression, anxiety, delirium, and emotional lability (67) . Because neuro-ICU patients are often unable to communicate their needs, clinicians must be especially vigilant for signs of discomfort (68) . Tachycardia and tachypnea may be the only manifestations of distress, although they are nonspecific. Treatment of these symptoms in patients with neurocritical illness is similar to that in the general critical care population (68) . Preparation for withdrawal of life-sustaining therapy includes having opioids available at the bedside prior to extubation to manage agonal breathing patterns and other signs of air hunger or distress. Anticholinergics (e.g., glycopyrrolate) can reduce tracheobronchial sections and gurgling (death rattle) for some patients, although no large-scale, placebo-controlled study has been conducted to confirm this effect (69) , and death rattle may not be correlated with patient respiratory distress (70) . Anxiolytics and other sedatives should be immediately available to treat agitation or anxiety. Some ICUs use specific titration goals, such as increasing the dose of opioids and/or sedatives to maintain a heart rate less than 100 beats/min or respiratory rate less than 20 breaths/ min. Such guidelines offer concrete guidance for nursing staff and may help prevent undertreatment of dyspnea and agitation.
Medications and interventions that do not offer symptom relief should be discontinued, including antibiotics, vasopressors/ inotropes, antithrombotics, IV hydration, artificial feeding, and patient monitors. Antiepileptic medications may be continued since a seizure is considered to be an uncomfortable complication.
Long-Acting Sedatives
It is unnecessary to wait for a washout of long-acting sedative medications (e.g., barbiturates) prior to withdrawal of life-sustaining therapy. A prolonged delay to withdrawal in this context can be emotionally difficult for families and staff. The concept of autonomy supports a patient's ability to limit life support measures at any time, even if there is residual medication effect (71) . Withdrawal in the context of long-acting sedatives is not causing death, but is "allowing the patient to die" from the underlying illness (72, 73) . In addition, the "principle of double effect" supports the use of a therapy that is intended to provide symptom relief (such as pentobarbital and other long-acting sedatives for delirium or sleep disruption at end of life) (74) (75) (76) (77) (78) (79) , even if death is hastened as a secondary effect of the therapy (80) .
Organ Donation-Donation After Cardiac Death
Organ donation after cardiac death (DCD) and donation following brain death (death by neurologic criteria [DNC]) are important considerations for neurocritically ill patients. The opportunity to save lives through organ donation can provide solace to some grieving families (73, 81) . Late or missed referrals to the organ procurement organization (OPO) deprive the family and patient of the opportunity to donate organs. In the United States, all hospitals are required to notify their assigned OPO when specific criteria are met, such as loss of brainstem reflexes in a patient who may be approaching brain death or consideration of withdrawal of life-sustaining therapies. Early notification is essential to allow time for OPO determination of donor suitability and for family decision making. The decision to withdraw life-sustaining therapy should be made independently of discussions regarding organ or tissue donation, and withdrawal of life support should occur only after the family has had the opportunity to make an informed decision.
Following consent for DCD, extubation occurs in the operating room. The family should be offered the opportunity to be present and briefed on the organ recovery process, which entails antiseptic measures including prepping and draping prior to extubation. An OPO family counselor may be present in the operating room for additional family support. Valuable input may also be provided by a palliative care specialist/team (83), a social worker, and/or another clinician with appropriate training to support the family. DCD involves the use of some therapies (such as IV fluids, IV heparin, and hemodynamic monitoring) that support the donation process (73) . To set appropriate expectations, the family should be informed that not all patients are suitable donors. If cardiopulmonary death does not occur after extubation (generally within an hour) and the OPO decides that the patient is no longer a suitable donor, the patient will be returned to the ICU or transition to a palliative care unit or other hospital bed for end-of-life care (73) .
Organ Donation: DNC
When brain death is expected and imminent, the use of aggressive therapies (such as osmotic therapy) may be futile and lead to complications that can compromise organ donation. It is then reasonable to transition from "brain protective" strategies of care to "organ protective" strategies. Although this approach still involves intensive medical management (e.g., treatment of hypotension and diabetes insipidus), it allows time for families to come to terms with the concept of brain death and preserves organ homeostasis for possible donation.
Communicating the concept of DNC presents unique challenges, as this concept is not accepted in certain cultures or religions (83) . Concrete communication, such as "brain death means the patient is declared dead," is essential to avoid misunderstanding. In circumstances in which brain death is not accepted by the family, it is reasonable to continue mechanical ventilation for a limited time while supporting the family. Eliminating blood draws, electrolyte correction, and vasopressor use and allowing the patient to progress to cardiopulmonary death may be necessary. When the patient/ family has consented to donation, medical management may involve invasive diagnostic procedures to investigate donor suitability and therapies aimed at restoring perfusion, such as hormonal replacement and vasopressor support (81) . Families should be counseled as to these possibilities by the OPO and supported throughout the donation process.
Time to Death After Palliative Extubation
A common question raised by family members is, when will death occur following extubation? It is important to describe to the family what is likely to happen over the minutes, hours, or days following extubation. For example: "the patient may not be awake and may make sounds similar to snoring. We expect that the patient will drift into a deeper coma and not respond over the next few hours/days. Eventually the breaths will get further apart until they stop and death comes peacefully." Expected timing of death is relevant in the context of DCD because cessation of cardiopulmonary activity within 60 minutes of extubation is a requirement for DCD in most states. In a multicenter study of comatose patients with irreversible brain injury undergoing palliative extubation, 46% died within 60 minutes. Major predictors of death within 60 minutes included absent corneal reflex, absent cough, extensor or absent motor response, and oxygenation index more than 3.0 (where oxygenation index = [Fio 2 × mean airway pressure in cm H 2 O/Pao 2 in torr] × 100) (84) . Table 5 shows the Donation After Cardiac Death-for patients in neurocritical state scoring system to predict the likelihood of cardiopulmonary arrest after withdrawal of life support. Other authors have produced similar results using equivalent models (85) . ICU specialist opinion regarding the probability of death within 60 minutes after withdrawal of life-sustaining therapy has been found to be very accurate along with variables such as pH, Glasgow Coma Score, spontaneous respiratory rate, positive end-expiratory pressure level, and systolic blood pressure (86) . Withdrawal of life-sustaining therapies does not necessarily lead to imminent death. In studies based on the Nationwide Inpatient Sample, nearly 40% of patients with ischemic stroke who received thrombolysis and nearly 20% of patients with SAH who underwent withdrawal of life support survived to hospital discharge. The discharge destination may be a longterm care facility or hospice. Additionally, length of stay and mean hospital costs were lower in patients who underwent withdrawal (87, 88) .
CONCLUSIONS
Neurocritically ill patients and their families have needs that require integration of palliative care principles, practices, and services. Attention to the trajectory of neurocritical illness, utility and limitations of neuroprognostic tools, and the public perceptions of coma and survival, can help inform effective communication and decision making. A shared, value-based decision-making model for establishing goals of care and special consideration of symptom management and family support during withdrawal of life-sustaining therapy can help ensure the delivery of highquality palliative care to neurocritically ill patients. 
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A score of ≥ 3 was associated with a 74% probability of death within 60 min, whereas a score of 0-2 was associated with a 77% probability of survival beyond 60 min.
